Rick Dean is stepping down as the CEO of OncoHealth
Rick Dean, Member of Board of Directors at OncoHealth, posted on LinkedIn:
“After 7 great years at OncoHealth, I have decided to step down as the CEO. It has been an honor to lead this company to tremendous growth and success including growing contracted revenue by 500%, increasing our membership under management by 600%, increasing our customer base by 900%, raising $50m + of growth capital from tier 1 healthcare investors, (Oak HC/FT, McKesson Ventures, Baird Capital, Emerson Collective, Sandbox Industries) being selected an EY Entrepreneur of the Year finalist, and leading the company through our sale to Arsenal Capital Partners and McKesson in 2022. Further, our 2025 YOY revenue will grow 45% this year putting the company on very solid ground to continue its success.
I will continue to be a part of the company as a member of the Board of Directors, but am looking forward to stepping back from my day to day role to spend more time with my family and recharge my innovation batteries. Words can’t express my gratitude and thanks to all of the current and former OncoHealth employees, customers and investors for allowing me to lead such a mission driven and caring organization. Sharing a photo from the first day in our Atlanta office. We’ve grown tremendously since then.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023